Document: Agenda - Challenges in drug development, regulation and clinical practice in immune thrombocytopenia-2026/6/5

Document: Appendix 1: Acceptable intakes established for N-nitrosamines-2026/6/5

Document: Timetable: Safety referral (Article-20 and Article-31 pharmacovigilance)-2026/6/4

Document: Timetable: Safety referral (Article 107i, urgent Union procedure)-2026/6/4

Document: Timetable: Non-safety referrals-2026/6/4

Page: Artificial intelligence-2026/6/4

Document: 2025 AI Observatory report-2026/6/4

Document: Standard operating procedure for the contribution to the 3-yearly JIACRA reports-2026/6/4

Document: PDCO minutes of the 21-24 April 2026 meeting-2026/6/3

Page: Development of a reflection paper on the use of external controls for evidence generation in regulatory decision-making - Scientific guideline-2026/6/3